These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37627458)

  • 81. Genetics of canine myxomatous mitral valve disease.
    O'Brien MJ; Beijerink NJ; Wade CM
    Anim Genet; 2021 Aug; 52(4):409-421. PubMed ID: 34028063
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The immunohistochemical evaluation of selected markers in the left atrium of dogs with end-stage dilated cardiomyopathy and myxomatous mitral valve disease - a preliminary study.
    Janus I; Kandefer-Gola M; Ciaputa R; Noszczyk-Nowak A; Pasławska U; Tursi M; Nowak M
    Ir Vet J; 2016; 69():18. PubMed ID: 27980728
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Utility of Tissue Doppler Imaging in the Echocardiographic Evaluation of Left and Right Ventricular Function in Dogs with Myxomatous Mitral Valve Disease with or without Pulmonary Hypertension.
    Baron Toaldo M; Poser H; Menciotti G; Battaia S; Contiero B; Cipone M; Diana A; Mazzotta E; Guglielmini C
    J Vet Intern Med; 2016 May; 30(3):697-705. PubMed ID: 27177623
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease.
    Druzhaeva N; Nemec Svete A; Ihan A; Pohar K; Domanjko Petrič A
    J Vet Intern Med; 2021 Sep; 35(5):2112-2122. PubMed ID: 34236111
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Novel Approach to Assess Cardiac Function Using Systolic Performance and Myocardial Performance Indices From Simultaneous Electrocardiography and Phonocardiography Recordings in Dogs With Various Stages of Myxomatous Mitral Valve Disease.
    Gicana KRB; Lertwanakarn T; Tachampa K
    Front Vet Sci; 2021; 8():741115. PubMed ID: 34746282
    [No Abstract]   [Full Text] [Related]  

  • 86. Effect of cardiac and respiratory cycles on vertebral heart score measured on fluoroscopic images of healthy dogs.
    Olive J; Javard R; Specchi S; Bélanger MC; Bélanger C; Beauchamp G; Alexander K
    J Am Vet Med Assoc; 2015 May; 246(10):1091-7. PubMed ID: 25932934
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension.
    Yuchi Y; Suzuki R; Yasumura Y; Saito T; Teshima T; Matsumoto H; Koyama H
    J Vet Intern Med; 2023; 37(3):856-865. PubMed ID: 36994902
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Machine Learning Techniques for Canine Myxomatous Mitral Valve Disease Classification: Integrating Anamnesis, Quality of Life Survey, and Physical Examination.
    Engel-Manchado J; Montoya-Alonso JA; Doménech L; Monge-Utrilla O; Reina-Doreste Y; Matos JI; Caro-Vadillo A; García-Guasch L; Redondo JI
    Vet Sci; 2024 Mar; 11(3):. PubMed ID: 38535852
    [TBL] [Abstract][Full Text] [Related]  

  • 89. DELay of Appearance of sYmptoms of Canine Degenerative Mitral Valve Disease Treated with Spironolactone and Benazepril: the DELAY Study.
    Borgarelli M; Ferasin L; Lamb K; Bussadori C; Chiavegato D; D'Agnolo G; Migliorini F; Poggi M; Santilli RA; Guillot E; Garelli-Paar C; Toschi Corneliani R; Farina F; Zani A; Dirven M; Smets P; Guglielmini C; Oliveira P; Di Marcello M; Porciello F; Crosara S; Ciaramella P; Piantedosi D; Smith S; Vannini S; Dall'Aglio E; Savarino P; Quintavalla C; Patteson M; Silva J; Locatelli C; Baron Toaldo M
    J Vet Cardiol; 2020 Feb; 27():34-53. PubMed ID: 32032923
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Comparison of electrocardiographic parameters in dogs with different stages of myxomatous mitral valve disease.
    Na Y; Lee D; Yun T; Koo Y; Chae Y; Kim H; Yang MP; Kang BT
    Can J Vet Res; 2021 Oct; 85(4):261-270. PubMed ID: 34602730
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Evaluation of atrial natriuretic peptide and cardiac troponin I concentrations for assessment of disease severity in dogs with naturally occurring mitral valve disease.
    Hori Y; Iguchi M; Hirakawa A; Kamiya Z; Yamano S; Ibaragi T; Isayama N; Yamashita Y; Iwasa N; Inaba H; Heishima Y; Yuki M
    J Am Vet Med Assoc; 2020 Feb; 256(3):340-348. PubMed ID: 31961274
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs.
    Vezzosi T; Grosso G; Tognetti R; Meucci V; Patata V; Marchesotti F; Domenech O
    J Vet Intern Med; 2021 May; 35(3):1238-1244. PubMed ID: 33951235
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    Sudunagunta S; Green D; Christley R; Dukes-McEwan J
    J Vet Cardiol; 2019 Jun; 23():21-31. PubMed ID: 31174726
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease.
    Valente C; Guglielmini C; Baron Toaldo M; Romito G; Artusi C; Brugnolo L; Contiero B; Poser H
    Front Vet Sci; 2021; 8():738898. PubMed ID: 34604374
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease.
    Hong HJ; Oh YI; Park SM; An JH; Kim TH; Chae HK; Seo KW; Youn HY
    BMC Vet Res; 2022 Jul; 18(1):261. PubMed ID: 35790968
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Influence of concurrent lower respiratory tract disease on point-of-care lung ultrasound in small-breed dogs with myxomatous mitral valve disease.
    Lam MC; Lin CH; Lo PY; Wu HD
    J Vet Intern Med; 2022 May; 36(3):1075-1081. PubMed ID: 35475522
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A radiographic measurement of left atrial size in dogs.
    Sánchez Salguero X; Prandi D; Llabrés-Díaz F; Manzanilla EG; Bussadori C
    Ir Vet J; 2018; 71():25. PubMed ID: 30568788
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Evaluation of urinary neutrophil gelatinase-associated lipocalin to detect renal tubular damage in dogs with stable myxomatous mitral valve disease.
    Troia R; Sabetti MC; Crosara S; Quintavalla C; Romito G; Mazzoldi C; Fidanzio F; Cescatti M; Bertazzolo W; Giunti M; Dondi F
    J Vet Intern Med; 2022 Nov; 36(6):2053-2062. PubMed ID: 36196592
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prevalence and prognostic importance of pulmonary hypertension in dogs with myxomatous mitral valve disease.
    Borgarelli M; Abbott J; Braz-Ruivo L; Chiavegato D; Crosara S; Lamb K; Ljungvall I; Poggi M; Santilli RA; Haggstrom J
    J Vet Intern Med; 2015; 29(2):569-74. PubMed ID: 25818210
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Effect of body condition score on the interobserver variability of vertebral heart scale assessment in dogs.
    Bruining-Staal K; Tiemessen I; Vernooij JCM; Beijerink N
    Vet Radiol Ultrasound; 2024 Jul; ():. PubMed ID: 39054653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.